Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
30/04/2024 | 15:07 | IH Market News | Futures Pointing To Roughly Flat Open On Wall Street | NYSE:LLY | Eli Lilly and Co |
30/04/2024 | 13:59 | IH Market News | U.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate Decision | NYSE:LLY | Eli Lilly and Co |
30/04/2024 | 13:55 | IH Market News | HSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in Earnings | NYSE:LLY | Eli Lilly and Co |
30/04/2024 | 12:45 | PR Newswire (US) | Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum | NYSE:LLY | Eli Lilly and Co |
17/04/2024 | 12:15 | PR Newswire (US) | Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity | NYSE:LLY | Eli Lilly and Co |
16/04/2024 | 16:00 | PR Newswire (US) | Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement | NYSE:LLY | Eli Lilly and Co |
03/04/2024 | 13:12 | IH Market News | Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More | NYSE:LLY | Eli Lilly and Co |
11/03/2024 | 21:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LLY | Eli Lilly and Co |
11/03/2024 | 21:24 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LLY | Eli Lilly and Co |
10/03/2024 | 21:00 | PR Newswire (US) | More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study | NYSE:LLY | Eli Lilly and Co |
08/03/2024 | 12:45 | PR Newswire (US) | U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab | NYSE:LLY | Eli Lilly and Co |
07/03/2024 | 14:00 | PR Newswire (US) | Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care | NYSE:LLY | Eli Lilly and Co |
05/03/2024 | 23:00 | PR Newswire (US) | Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting | NYSE:LLY | Eli Lilly and Co |
20/02/2024 | 16:00 | PR Newswire (US) | Lilly to Participate in Cowen's 44th Annual Health Care Conference | NYSE:LLY | Eli Lilly and Co |
13/02/2024 | 23:04 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NYSE:LLY | Eli Lilly and Co |
09/02/2024 | 17:56 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:LLY | Eli Lilly and Co |
09/02/2024 | 15:30 | PR Newswire (US) | Philip Johnson to Retire as Lilly Treasurer | NYSE:LLY | Eli Lilly and Co |
08/02/2024 | 22:51 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NYSE:LLY | Eli Lilly and Co |
07/02/2024 | 23:08 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NYSE:LLY | Eli Lilly and Co |
06/02/2024 | 12:45 | PR Newswire (US) | Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | NYSE:LLY | Eli Lilly and Co |
06/02/2024 | 12:27 | IH Market News | US Index Futures Mixed, Oil Prices Edge Higher | NYSE:LLY | Eli Lilly and Co |
29/01/2024 | 12:09 | IH Market News | Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest news | NYSE:LLY | Eli Lilly and Co |
29/01/2024 | 12:09 | IH Market News | Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street Highlights | NYSE:LLY | Eli Lilly and Co |
25/01/2024 | 14:45 | Dow Jones News | Eli Lilly Executive VP of Global Quality Johna Norton to Retire | NYSE:LLY | Eli Lilly and Co |
25/01/2024 | 14:00 | PR Newswire (US) | Johna Norton to Retire as Lilly Executive Vice President of Global Quality | NYSE:LLY | Eli Lilly and Co |
23/01/2024 | 18:00 | PR Newswire (US) | Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting | NYSE:LLY | Eli Lilly and Co |
23/01/2024 | 16:00 | PR Newswire (US) | Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance | NYSE:LLY | Eli Lilly and Co |
22/01/2024 | 11:48 | IH Market News | Wall Street Highlights: Sony Abandons Billion-Dollar Merger, SolarEdge Announces 16% Workforce Reduction, and More | NYSE:LLY | Eli Lilly and Co |
10/01/2024 | 14:45 | InvestorsHub NewsWire | GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons | NYSE:LLY | Eli Lilly and Co |
05/01/2024 | 16:39 | Dow Jones News | Trending: Lilly Launches Direct-to-Consumer Website | NYSE:LLY | Eli Lilly and Co |